
Pure Global: Brazil's MedTech Renewal Ambush & ANVISA's Costly Registration Traps
LATAM MedTech Insights · Ran Chen
January 19, 20262m 1s
Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week, we dive into a silent but significant threat to MedTech companies in Brazil: the complexities of ANVISA's registration renewal process. Many manufacturers of Class I and II devices are unaware of the critical differences between a 'Notificação' and a 'Cadastro' approval, leading to a false sense of security.
We explore how this simple misunderstanding can lead to the sudden cancellation of a product license, halting all sales and imports. This episode is a crucial guide for any company that wants to maintain its foothold and avoid the costly pitfalls of non-compliance in Latin America's largest market.
**Case Study:** Imagine your company's Class II device has been successful in Brazil for nine years. Business is stable. Suddenly, you discover that your ANVISA registration is about to be cancelled permanently because your team missed the one-year deadline for the mandatory renewal application. Your entire Brazilian operation is now at risk from a single administrative oversight.
**Key Questions from this Episode:**
* Is your Brazilian device approval a one-time 'Notificação' or a time-limited 'Cadastro'?
* Do you know the exact expiration date of your current ANVISA registration?
* When is the final deadline to submit your renewal application before you risk cancellation?
* What key documents are required for re-registration that weren't needed for the initial approval?
* How can your local Brazil Registration Holder (BRH) fail to protect you from this risk?
* Could this simple administrative mistake cost your company millions in lost revenue?
* What is the first step to take today to audit your compliance status?
Navigating the complexities of global markets is our expertise. Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, combining local experts with advanced AI to streamline market access. From acting as your local representative to managing the entire submission and renewal process, we ensure your market presence is secure. Don't let regulatory surprises disrupt your business. Contact us for a consultation at [email protected] or visit https://pureglobal.com/.